Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Saudi Arabia
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2433
https://www.valueinhealthjournal.com/article/S1098-3015(15)04509-X/fulltext
Title :
Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04509-X&doi=10.1016/j.jval.2015.09.2433
First page :
A667
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1846